| Detected | Trial | Change |
|---|---|---|
| 2026-06-12 | NCT06532032 A Study of Combination Therapy With Amivantamab and Docetaxel in Participants With… |
Trial completed |
| 2026-06-06 | NCT06750094 A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… |
Trial sites expanded: 241 -> 247 locations |
| 2026-06-06 | NCT07276399 A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… |
Trial sites expanded: 177 -> 186 locations |
| 2026-06-03 | NCT05663866 Premedication to Reduce Amivantamab Associated Infusion Related Reactions |
date change Completion pushed: 2026-07-30 -> 2027-03-31 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-05-14 | NCT07586202 A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06662786 | A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI… | Colorectal Neoplasms | Recruiting |
| NCT06750094 | A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… | Colorectal Neoplasms | Recruiting |
| NCT07276399 | A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC… | Squamous Cell Carcinoma of Head and Neck | Recruiting |
| NCT04487080 | A Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib in Locally… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT04538664 | A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT04988295 | A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| Phase 2 | |||
| NCT07392658 | Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With… | Metastatic NSCLC - Non-Small Cell Lung Cancer | Recruiting |
| NCT05845450 | Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer… | Colorectal Cancer | Recruiting |
| NCT06116682 | Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of… | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT05498428 | A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including… | Carcinoma, Non-small-Cell Lung | Recruiting |
| NCT06667076 | A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT05601973 | Amivantamab, Lazertinib and Bevacizumab in Patients With EGFR-mutant Advanced Non-small… | Non Small Cell Lung Cancer | Active, Not Recruiting |
| NCT05117931 | A Study of Amivantamab in People With Esophagogastric Cancer | Esophagogastric Cancer | Active, Not Recruiting |
| NCT05801029 | A Study to Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants… | Non-Small Cell Lung Cancer (NSCLC) | Active, Not Recruiting |
| NCT05074940 | Amivantamab in Adenoid Cystic Carcinoma | Salivary Gland Cancer | Active, Not Recruiting |
| NCT06120140 | Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT05663866 | Premedication to Reduce Amivantamab Associated Infusion Related Reactions | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT07586202 | A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants… | Carcinoma, Non-Small-Cell Lung | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT05379595 | A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in… | Advanced or Metastatic Colorectal Cancer | Recruiting |
| NCT06385080 | A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants… | Squamous Cell Carcinoma of Head and Neck | Recruiting |
| NCT07227025 | A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic… | Carcinoma, Non-Small-Cell Lung | Recruiting |
| NCT05845671 | Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or… | Lung Cancer | Active, Not Recruiting |
| NCT06083857 | PhI/II Study of Amivantamab and Tepotinib Combo in MET-altered Non-small Cell Lung Cancer | Non-small Cell Lung Cancer | Active, Not Recruiting |
| NCT05488314 | A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| NCT05908734 | A Study of Combination Therapy With Amivantamab and Cetrelimab in Participants With… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |